No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
OII Oceaneering International
- 24.900
- +0.350+1.43%
Close Apr 26 16:00 ET
- 24.900
- 0.0000.00%
Post 18:48 ET
2.52BMarket Cap23.49P/E (TTM)
24.940High24.190Low1.10MVolume24.430Open24.550Pre Close27.15MTurnover1.10%Turnover Ratio26.21P/E (Static)101.39MShares27.46052wk High4.05P/B2.48BFloat Cap14.99052wk Low--Dividend TTM99.71MShs Float79.892Historical High--Div YieldTTM3.06%Amplitude1.929Historical Low24.669Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Benchmark Reiterates Buy on Oceaneering International, Maintains $34 Price Target
Oceaneering International Inc (OII) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...
Express News | Oceaneering International Inc : Zephirin Group Raises Price Objective to $30 From $24
Earnings Call Summary | Oceaneering International(OII.US) Q1 2024 Earnings Conference
The following is a summary of the Oceaneering International, Inc. (OII) Q1 2024 Earnings Call Transcript:Financial Performance:Oceaneering International reported Q1 2024 net income of $15.1 million ($
Oceaneering Price Target Maintained With a $34.00/Share by Benchmark
Oceaneering Price Target Maintained With a $34.00/Share by Benchmark
Oceaneering International Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/25/2024 46.02% Benchmark → $34 Reiterates Buy → Buy 03/11/2024 3.07% Piper Sandler $23 → $24 Maintains
Comments
The modest level of insider ownership and lack of insider transactions in the last three months suggest alignment with shareholder interests. However, significant insider selling over the past year could be a red flag for investors.
Insiders At Oceaneering International Sold US$2.5m In Stock, Alluding To Potential WeaknessOceaneering International, Inc.'s transition from loss to profitability justifies its strong share price gain. Despite slowing gains, the company's future financial health remains crucial for shareholders.
Oceaneering International's respectable ROE is overshadowed by its high debt level. Investors should consider the company's performance potential in less favorable credit markets. High ROE without debt typically indicates a high-quality business.
ColumnsToday's pre-market stock movers: DOCU, BGNE, RBLX, SFIX and more
Gainers:
• $Cogent Biosciences(COGT.US$ +7.9% (announces positive initial clinical data from ongoing phase 2 APEX trial evaluating bezuclastinib in patients with advanced systemic mastocytosis)
• $Univar Solutions(UNVR.US$ +7.2% (expands distribution partnership with BASF)
• $Vail Resorts(MTN.US$ +6% (In reaction to earnings/guidance)
• $BeiGene(BGNE.US$ +5.4% (highlights growing portfolio and pipeline targeting hematologic mali...
• $Cogent Biosciences(COGT.US$ +7.9% (announces positive initial clinical data from ongoing phase 2 APEX trial evaluating bezuclastinib in patients with advanced systemic mastocytosis)
• $Univar Solutions(UNVR.US$ +7.2% (expands distribution partnership with BASF)
• $Vail Resorts(MTN.US$ +6% (In reaction to earnings/guidance)
• $BeiGene(BGNE.US$ +5.4% (highlights growing portfolio and pipeline targeting hematologic mali...
17
7
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg